Intra-Cellular Therapies (ITCI) Announces $350M Public Offering of Common Stock
Intra-Cellular proposes $350 million underwritten public offering. In addition, with the update of positive final-phase test results for a treatment for certain bipolar disorders, ITCI stock surged 73% on Wednesday. Intra-Cellular Therapies, Inc. (ITCI) stock made a massive move on Wednesday surging up to 73% at close. The stock price sky-rocketed initially from the update […]
